People with Lp(a) gene variant may benefit from daily aspirin

An inexpensive blood test that checks for a genetic variant of Lp(a)—a fatty particle similar to LDL cholesterol—may help clarify who might benefit from a daily low-dose aspirin, according to a 2025 review of study findings.